BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 5:13:00 PM | Browse: 1315 | Download: 1047
 |
Received |
|
2013-09-27 06:57 |
 |
Peer-Review Started |
|
2013-09-27 11:49 |
 |
To Make the First Decision |
|
2013-11-05 09:33 |
 |
Return for Revision |
|
2013-11-05 09:50 |
 |
Revised |
|
2013-11-26 08:14 |
 |
Second Decision |
|
2014-01-06 18:22 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-06 18:57 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-01-15 21:01 |
 |
Publish the Manuscript Online |
|
2014-01-26 20:08 |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Topic Highlights |
Article Title |
Colorectal cancer biomarkers: To be or not to be? Cautionary tales from a road well travelled
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kim YC Fung, Edouard Nice, Ilka Priebe, Damien Belobrajdic, Aloke Phatak, Leanne Purins, Bruce Tabor, Celine Pompeia, Trevor Lockett, Timothy E Adams, Antony Burgess and Leah Cosgrove |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
CSIRO Preventative Health National Research Flagship and the National Health and Medical Research Council |
1017078 |
|
Corresponding Author |
Kim YC Fung, PhD, CSIRO, Preventative Health National Research Flagship, PO Box 10041, Adelaide, SA 5000, Australia. kim.fung@csiro.au |
Key Words |
Biomarker; Bias; Colorectal cancer; Diagnostic; Discovery; Validation |
Core Tip |
The identification of sensitive and specific biomarkers for the early diagnosis and surveillance of colorectal cancer is recognised as being fundamental to improve survival for this disease. Studies involving analyses of multiple biomarkers require consideration of many potential confounding issues, some of which are impossible or difficult to control for. Implementation of strategies which can overcome and account for potentially confounding variables is essential to ensure robust verification and validation of potential biomarkers and their successful evaluation in large and meaningful clinical cohorts that are representative of the target population, ultimately with successful translation into the clinic. |
Publish Date |
2014-01-26 20:08 |
Citation |
Fung KYC, Nice E, Priebe I, Belobrajdic D, Phatak A, Purins L, Tabor B, Pompeia C, Lockett T, Adams TE, Burgess A, Cosgrove L. Colorectal cancer biomarkers: To be or not to be? Cautionary tales from a road well travelled. World J Gastroenterol 2014; 20(4): 888-898 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i4/888.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i4.888 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345